NCT07192471 2026-04-20A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaKyowa Kirin Co., Ltd.Phase 1 Not yet recruiting72 enrolled
NCT07535762 2026-04-17Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell LymphomaShanghai Jiao Tong University School of MedicinePhase 2 Not yet recruiting36 enrolled